Oral sulfonylurea study for children with KCNJ11-related delay and epilepsy
Part of Brain & nervous system, Mental health clinical trials.
This study looks at whether switching to an oral sulfonylurea medicine can improve thinking, development, and seizure-related outcomes in children with a specific KCNJ11 gene change. You may be able to join if your child already has this mutation and has been able to take the medicine by mouth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is at least 2 years old
- Your child has a specific KCNJ11 gene change called V59M (heterozygous)
- Your child has already switched successfully to taking sulphonylurea by mouth
- Your child is willing to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a ketogenic diet works for children with hard-to-treat epilepsy or certain other diseases. It aims to see if the diet improves quality of life.
This study looks at children with epilepsy and movement disorders to better understand the genes involved. It aims to help doctors recognize and treat these conditions more effectively.
This study aims to better understand SCN1A-related epilepsies by following patients over time. Researchers hope to learn more about how the condition progresses to help develop future treatments.
This trial tests a medication called SGLT2 inhibitor (a type of diabetes drug that may also help protect the kidneys) in children with chronic kidney disease. It aims to see if the drug is safe and easy to use in children ages 2–18 with moderate to severe kidney problems.
This study tests a new medicine (S230815) given by lumbar puncture (spinal tap) to see if it helps reduce seizures in children with a specific genetic cause of epilepsy. It is for children aged 2 to 12 who have not responded well to other treatments.
This trial tests whether daily warm baths at home can help reduce seizures in children with CDKL5 deficiency disorder—a rare genetic condition that causes hard-to-control epilepsy. The study wants to see if heat therapy is safe and actually works for these children.
Hear when a new Neurodevelopmental Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.